Coventry Capital US LLC v. EEA Life Settlements, Inc. et al

Filing 337

ORDER granting 334 Letter Motion to Seal. The Letter-Motion at ECF No. 334 to file the documents at ECF No. 335 under seal is GRANTED. The documents at ECF No. 335 shall remain visible only to the selected parties. The Clerk of Court is respectfully directed to close the Letter-Motion at ECF No. 334. SO ORDERED. (Signed by Magistrate Judge Sarah L Cave on 5/24/22) (yv)

The Letter-Motion at ECF No. 334 to file the documents at ECF No. 335 under seal is GRANTED. The documents at
ECF No. 335 shall remain visible only to the selected parties.
The Clerk of Court is respectfully directed to close the Letter-Motion at ECF No. 334.
KENNETH J. BROWN

SO ORDERED 05/24/20222

May 23, 2022
Via ECF
The Honorable Sarah L. Cave
United States District Court for the Southern District of New York
500 Pearl Street, Room 1670
New York, NY 10007
Re: Coventry Capital US LLC v. EEA Life Settlements, Inc., No. 17-cv-7417-VM-SLC
Dear Judge Cave:
I write on behalf of Coventry Capital US LLC (“Coventry”) regarding Coventry’s May 23,
2022 letter. Coventry filed its letter and exhibits publicly on ECF, but did not file public versions
of Exhibits 1–4 (collectively, the “Exhibits”). Those exhibits are excerpts from the deposition
testimony of Charles Brinkley, Gary Kuchera, Reid Buerger, and Joshua May. Pursuant to the
Amended Protective Order (Dkt. No. 255) and the parties’ subsequent March 7, 2022 agreement
concerning the designation of deposition testimony, Coventry designated the transcripts of those
depositions provisionally “Confidential” and intends to designate the specific pages and lines of
those transcripts that comprise the Exhibits as “Confidential” pursuant to the Protective Order
within 30 days of receipt of final copies of each deposition transcript. Accordingly, pursuant to ¶
I.G of the Court’s Individual Practices, Coventry requests leave to file those exhibits under seal.
Coventry seeks sealed treatment of the Exhibits because they contain examination of
Coventry witnesses on confidential and commercially sensitive topics concerning Coventry’s
processes for conducting diligence on life-insurance policies and portfolios it is considering
purchasing. Similar interests led Defendant EEA Life Settlements, Inc. (“EEA”) to request sealed
treatment of exhibits submitted in connection with prior discovery disputes, e.g., Dkt. No. 245;
Dkt. No. 251, which requests the Court granted, e.g., Dkt. No. 248; Dkt. No. 254. In addition,
portions of the Exhibits include reference to the full names of particular insureds from EEA’s
portfolio, as well as information about those insureds, including their medical condition. Coventry
also seeks sealed treatment of the Exhibits to protect the privacy of those individuals.
We appreciate the Court’s attention to these matters and are prepared to address them
further at the Court’s convenience.

May 23, 2022
Page 2
Respectfully submitted,

Kenneth J. Brown